Evidence map›Paper›PMID 42138624›Full record

ArticleInternational journal of surgical pathology2026

A Periadrenal Gland Ewing Sarcoma With Extensive Posttreatment Ganglioneuroblastoma-Like Morphology in an Adult Patient.

Xi Wang, William Laskin, Hao Wu

Abstract readCase Reports
In one paragraph

Article in International journal of surgical pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xi WangDepartment of Pathology, Cleveland Clinic, Cleveland, OH, USA.
William LaskinDepartment of Pathology, Yale School of Medicine/Yale-New Haven Hospital, New Haven, CT, USA.
Hao WuDepartment of Pathology, Yale School of Medicine/Yale-New Haven Hospital, New Haven, CT, USA.ORCID 0000-0002-8903-4658

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroblastoma and Ewing sarcoma are two round cell malignancies that can exhibit light microscopic overlap and potentially arise in the same anatomic location, leading to diagnostic uncertainty. Neoadjuvant chemotherapy-induced cytodifferentiation/maturation is a common feature in pediatric malignancies, whereas Ewing sarcomas often exhibit variable degrees of necrosis, inflammatory infiltrates, and stromal fibrosis after neoadjuvant treatment. Posttreatment neuroblastoma-like morphologic changes have been rarely reported in pediatric Ewing sarcoma. Herein, we report a 33-year-old man with a retroperitoneal periadrenal mass and normal plasma catecholamine levels. The tumor biopsy demonstrated Homer-Wright rosette-forming small round cells with a high nuclear-to-cytoplasmic ratio and finely granular chromatin. The tumor cells showed strong, diffuse membranous CD99 and nuclear NKX2.2 expression, whereas they were negative for PHOX2B, a neuroblastoma/ganglion cell marker.

Indexed as

Adrenal Gland NeoplasmsGanglioneuroblastomaSarcoma, Ewing12E7 AntigenAdultBiomarkers, TumorGene RearrangementHomeobox Protein Nkx-2.2Homeodomain ProteinsHumansMaleNeoadjuvant TherapyNuclear ProteinsRNA-Binding Protein EWSTranscription FactorsZebrafish Proteins12E7 AntigenBiomarkers, TumorCD99 protein, humanEWSR1 protein, humanHomeobox Protein Nkx-2.2Homeodomain Proteinsnkx2.2b protein, zebrafishNKX2-2 protein, humanNuclear ProteinsRNA-Binding Protein EWSTranscription FactorsZebrafish ProteinscytodifferentiationEwing sarcomaneoadjuvant chemotherapyneuroblastoma

Identifiers

PMID42138624
PMCPMC13547690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.